Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon

Table 6 MLL2 expression and clinicopathological variables in breast cancer (n = 96)

	Number of cases positive for nuclear MLL2	Number of positive cases where T > B (%)
	35	27 (77)
Lymph node
Negative	20	19 (95)***
Positive	15	8 (53)
Tumor stage
Early	12	11 (92)**
Advanced	23	16 (70)

Clinicopathological variables associated with elevated levels of nuclear MLL2 immunoreactivity in patients with invasive colon carcinoma; **p = 0.03; ***p = 0.005

ISSN: 1475-2867